Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1149-1155

  Molrine, D C ^a   Guinan, E C ^a,b   Antin, J H ^c   Wheeler, C ^d   Parsons, S K ^a,b   Weinstein, H J ^a,b   McGarigle, C ^c   Blanding, P ^a   Phillips, N R ^a   Ciamarra, A ^a   George, S ^a   Ambrosino, D M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Active; Bacterial; Bone marrow transplantation; Conjugate; Immunization; Polysaccharides; Vaccines

Indexed keywords

PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VIRUS ANTIBODY; VIRUS VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL INFECTIONS; BACTERIAL VACCINES; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; TRANSPLANTATION, AUTOLOGOUS; VACCINES, CONJUGATE;

EID: 8944262189     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 368-380.
2. Armitage RJ, Goldstone AH, Richards JDM, Cawley JC. Lymphocyte function after autologous bone marrow transplantation (BMT): a comparison with patients treated with allogeneic BMT and with chemotherapy only. Br J Haematol 1986; 63: 637-647.
3. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
4. Witherspoon RP, Lum LG, Storb R, Thomas ED. In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3-4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy. Blood 1982; 59: 844-850.
5. Pedrazzini A, Freedman AS, Anderson J et al. Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood 1989; 74: 2203-2211.
6. Anderson KC, Ritz J, Takvorian T et al. Hematologic engraftment and immune reconstitution post-transplantation with anti-B1 purged autologous bone marrow. Blood 1987; 69: 597-604.
7. Baumgartner C, Morell A, Hirt A et al. Humoral immune function in pediatric patients treated with autologous bone marrow transplantation for B cell non-Hodgkin's lymphoma. The influence of ex vivo marrow decontamination with anti-Y 29/55 monoclonal antibody and complement. Blood 1988; 71: 1211-1217.
8. Atkinson K, Storb R, Prentice RI et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 360-368.
9. Winston DJ, Schiffman G, Wang DC et al. Pneumococcal infections after human bone marrow transplantation. Ann Intern Med 1979; 91: 835-841.
10. Sheridan JF, Tutschka PJ, Sedmak DD, Copelan EA. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 1990; 75: 1583-1586.
11. Hoyle C, Goldman JM, on behalf of 18 UK bone marrow transplant teams. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1994; 14: 247-252.
12. Martino R, Altes A, Nomdedeu J et al. Atypical presentation of pneumococcal pneumonia in a patient undergoing bone marrow transplantation for Hodgkin's disease. Bone Marrow Transplant 1994; 14: 174-175.
13. Guinan EC, Molrine DC, Antin JH et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677-684.
14. Winston DJ, Winston GH, Schiffman G et al. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 1983; 143: 1735-1737.
15. Barra A, Cordonnier C, Preziosi MP et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021-1028.
16. Insel RA, Andersen PW. Response to oligosacharride-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. New Engl J Med 1986; 315: 499-503.
17. Sallan S, Neimeyer CM, Billett AL et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 1989; 7: 1594-1601.
18. Billett AL, Kommehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993; 81: 1651-1657.
19. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia using ex. vivo marrow treatment with 4-hydroperoxy-cyclophosphamide. New Engl J Med 1986; 315: 141-147.
20. Siber GR, Ambrosino DM. Heavy and light chain restriction of human antibodies to polysaccharide antigens. In: Nydegger UE, Morell A (eds). Clinical Use of Intravenous Immunoglobulins. Academic Press: London, 1986, pp 47-50.
21. Quataert S, Quackenbush-Wiedl L, Phipps DC, Madore DV. Quantitation of anti-polysaccharide antibodies in a new human reference serum for Streptococcal pneumoniae. Pediatr Res 1993; 33: 179a (Abstr. 1057).
22. Carlone GM, Frasch CE, Siber GR et al. Multicenter comparison of antibody levels to Neisseria meningitidis group A capsular polysaccharide using a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 1992; 30: 154-159.
23. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.
24. Orenstein WA, Weisfeld JS, Halsey NA. Diphtheria and Tetanus Toxoids and Pertussis Vaccine, Combined. Publication 451. Pan American Health Organization, World Health Organization: Washington, DC, 1983, p 30.
25. + T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
26. Annett G, Weinberg K, Kashyap A et al. Post-transplantation thymic function predicts immunocompetence. Blood 1994; 84: 250a (Abstr. 985).
27. Pauksen K, Hammerström V, Ljungman P et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994; 18: 547-552.
28. Pauksen K, Daraj V, Ljungman P et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427-432.
29. Molrine DC, Guinan EC, Antin JH et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012-3018.
30. Mangan KF. Peripheral blood stem cell transplantation: from laboratory to clinical practice. Semin Oncol 1995; 22: 202-209.
31. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
32. Henon PhR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
33. Kiesel S, Pezzutto A, Moldenhauer G et al. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood 1988; 72: 672-678.
34. Chan CY, Molrine DC, Antin JH et al. Antibody responses following autologous peripheral blood stem cell transplantation. Infectious Diseases Society of America (33rd Annual Meeting) 1995, p 120 (Abstr. 415).
35. 197 conjugate vaccines in healthy US infants. Pediatr Res 1994; 35: 177a (Abstr. 1048).
36. Schuchter LM, Wingard JR, Piantadosi S et al. Herpes zoster infection after autotogous bone marrow transplantation. Blood 1989; 74: 1424-1427.
37. Wingard JR, Chen D Y-H, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988; 71: 1432-1437.
38. Reusser P, Fisher LD, Buckner CD et al. Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. Blood 1990; 75: 1888-1894.